Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by postie1on May 13, 2024 7:31pm
111 Views
Post# 36037778

RE:Something Fundamentally Wrong

RE:Something Fundamentally Wrong Not scratching one little bit. 

1.  I do not think that website is intended for the invester as much as it is intended for the buyers of the product.

2.   I still think it is going to take money flow and/or financing to get the price going north. This company is imo past the honeymoon stage and is now at the "show me the money' stage for investors.

3.   Will product sales lead to a buyout offer by a larger company that does not need to raise funds for FC. After all the larger the sales, the more countries, the larger the Barite deposit , the more products, the more that C60 is proven,  the more expensive a buyout becomes which is fine by me unless an offer north of $1 were to happen fairly quickly.

<< Previous
Bullboard Posts
Next >>